Skip to content
Screener

Absci Corporation ABSI Other Income (Expense)

Other Income (Expense) at other companies

Schrodinger logo
SchrodingerSDGR
$48.89M+388%
Recursion Pharmaceuticals, Inc. logo
Recursion Pharmaceuticals, Inc.RXRX
$3.96M-8.5%
Spyre Therapeutics, Inc. logo
Spyre Therapeutics, Inc.SYRE
-$23.36M-366%
AbCellera Biologics Inc. logo
AbCellera Biologics Inc.ABCL
$3.81M-71.2%
AnaptysBio, Inc. logo
AnaptysBio, Inc.ANAB
-$18.21M-55.0%
Assembly Biosciences logo
Assembly BiosciencesASMB
$2.29M+104%

Segments

By segment

See full
Segment One-$3K+78.6%

Other financials

Income statement

See full
Revenue$215.0K-81.8%
Operating income-$30.8M-11.2%
Net income-$29.6M-12.3%
EPS (diluted)-$0.19+9.5%

Balance sheet

See full
Cash & equivalents$9.7M-84.9%
Total debt$4.0M-37.2%
Total equity$172.0M-13.5%
Total assets$195.6M-15.9%

Cash flow

See full
Operating cash flow-$26.3M-20.5%
CapEx$30.0K+20.0%
Free cash flow-$26.3M-20.5%

Valuation

See full
Market cap$1.41B+235%
Enterprise value$1.4B+279%
P/S765.8×+664×

Profitability

See full
Operating margin-6,723%-14,525pp
Net margin-6,450.8%-13,699pp
FCF margin-5,365.2%-9,300pp

Returns & leverage

See full
Return on equity-63.9%+28.0pp
Debt / equity0.0×
Current ratio6.6×+0.9×

Where this comes from

Reported directly by Absci Corporation in its filing.

Tagged under the XBRL concept us-gaap:NonoperatingIncomeExpense.

The source filing: Absci Corporation’s 10-Q, filed May 7, 2026.

Filed
May 7, 2026, 4:24 PM EDT
Fiscal quarter
Q1 FY2026
Calendar quarter
Q1 2026
Accession
0001672688-26-000088
(In thousands, except for share and per share data)For the Three Months Ended March 31, 20262025
Other income (expense)
Interest expense(18)(79)
Other income, net1,2831,458
Total other income, net1,2651,379
Loss before income taxes(29,581)(26,350)
Income tax expense (benefit)(18)4
Net loss$(29,599)$(26,346)
Net loss per share:Basic and diluted$(0.19)$(0.21)

Item 1. Unaudited Condensed Consolidated Financial Statements

FAQ

What is Absci Corporation's other income (expense)?
Absci Corporation (ABSI) reported other income (expense) of $1.27M in Q1 2026.
How has Absci Corporation's other income (expense) changed year-over-year?
Absci Corporation's other income (expense) decreased by 8.3% year-over-year, from $1.38M to $1.27M.
What is the long-term trend for Absci Corporation's other income (expense)?
Over 4 years (2021 to 2025), Absci Corporation's other income (expense) has grown at a -37.7% compound annual growth rate (CAGR), from -$34.62M to $5.2M.
What does other income (expense) mean?
Net total of all non-operating income and expenses not classified in specific line items — a catch-all for miscellaneous financial items.

Ask your AI about Absci Corporation's other income (expense).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude